Table 1.
Clinical characteristics
| Study population (n = 282) | Group I (n = 199) | Group II (n = 57) | Group III (n = 26) | P-value | |
|---|---|---|---|---|---|
| Age | 58 ± 16.4 | 54.1 ± 16.3 | 69.6 ± 11.4 | 65.5 ± 12.1 | <0.001 |
| BMI | 29.2 ± 5.6 | 29.0 ± 6.0 | 29.5 ± 4.6 | 29.5 ± 4.3 | 0.8 |
| sBP | 120.8 ± 19.4 | 119.4 ± 19.0 | 124.9 ± 20.3 | 122.1 ± 19.7 | 0.15 |
| dBP | 69.1 ± 10.5 | 69.8 ± 9.9 | 66.3 ± 10.9 | 70.5 ± 12.8 | 0.06 |
| Heart rate | 66.3 ± 10.8 | 67.2 ± 10.9 | 63.1 ± 9.5 | 66.5 ± 12.5 | 0.04 |
| Number of RF | 2.5 ± 1.5 | 2.1 ± 1.4 | 3.2 ± 1.2 | 3.5 ± 1.1 | <0.001 |
| Number of CV drugs | 2.8 ± 2.2 | 2.0 ± 1.9 | 4.2 ± 1.9 | 5.7 ± 1.5 | <0.001 |
| Male gender (%) | 61 | 50.5 | 87.7 | 84.6 | <0.001 |
| CV family history (%) | 41 | 38 | 48 | 48 | 0.3 |
| Dyslipidemia (%) | 72 | 61 | 94 | 100 | <0.001 |
| Hypertension (%) | 54 | 44 | 74 | 81 | <0.001 |
| Diabetes mellitus (any; %) | 13 | 7 | 28 | 31 | <0.001 |
| Obesity (BMI > 30; %) | 40 | 37 | 46 | 42 | 0.51 |
| Smoking history (%) | 27 | 21 | 35 | 54 | <0.001 |
Group I, patients with at least one CV RF; Group II, patients with a history of significant but stable CAD (history of stenting or coronary artery bypass grafting); Group III, patients with a history of myocardial infarction. sBP, systolic blood pressure; dBP, diastolic blood pressure; RF, risk factor; CV, cardiovascular; BMI, body mass index. P-value for Groups I–III.